Synergistic role of gut-microbial L-ornithine in enhancing ustekinumab efficacy for Crohn’s disease
Zhenyu Wang(Henan Provincial People's Hospital), Jie Hong(Shanghai Jiao Tong University), Yilu Zhou(Shanghai Jiao Tong University), Baoqin Xuan(Shanghai Jiao Tong University), Nan Shen(Cincinnati Children's Hospital Medical Center), Xuejie Chen(Central South University), Jinmei Ding(Shanghai Jiao Tong University), Xiaoqiang Zhu(Shanghai Jiao Tong University), Yi Jiang(Renji Hospital), Haoyan Chen(Shanghai Jiao Tong University), Zhijun Cao(State Key Laboratory of Animal Nutrition), Lijun Ning(Shanghai Jiao Tong University), Xiaowen Huang(Renji Hospital), Xiaoyan Wang(University of Arkansas for Medical Sciences), Ying Zhao(Shanghai Jiao Tong University), Yanru Ma(Renji Hospital), Tian Li(Air Force Medical University), Muni Hu(Shanghai Jiao Tong University), Jing‐Yuan Fang(Shanghai Jiao Tong University)
Cited by 30
Related Papers
Comprehensive review of targeted therapy for colorectal cancer
|Signal Transduction and Targeted Therapy|2020|1.7k
Low-dose interleukin-2 treatment selectively modulates CD4+ T cell subsets in patients with systemic lupus erythematosus
|Nature Medicine|2016|570
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
|Nature Communications|2019|427
Microbiome and metabolome features in inflammatory bowel disease via multi-omics integration analyses across cohorts
|Nature Communications|2023|231